Karyopharm Therapeutics, Inc. (KPTI)
6.42
+0.53
(+9.00%)
USD |
NASDAQ |
Dec 09, 16:00
6.42
0.00 (0.00%)
After-Hours: 17:06
Karyopharm Therapeutics Total Liabilities (Quarterly): 365.49M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| TG Therapeutics, Inc. | 417.81M |
| Actinium Pharmaceuticals, Inc. | 42.37M |
| Axsome Therapeutics, Inc. | 595.52M |
| Krystal Biotech, Inc. | 102.22M |
| Akebia Therapeutics, Inc. | 322.56M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 96.23M |
| Shareholders Equity (Quarterly) | -269.26M |
| Debt to Equity Ratio | -0.7295 |
| Current Ratio | 1.030 |
| Net Debt Paydown Yield | -0.28% |